Opportunity
Brand Name - Dectomax (Doramectin) 500mL Injectable Solution
Response due
October 30, 2026
- Buyer
- Mrpbs Minneapolis Mn
- Agency
- Mrpbs Minneapolis Mn
- Estimated value
- Not stated
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Part 12. This announcement constitutes the only solicitation. Quotations are being requested and a separate written solicitation will not be issued. Solicitation number 12639527Q0009 is issued as a Request for Quotation (RFQ) for 2400 bottles of Dectomax 500 ml Injectable solution. This acquisition is set-aside for small business concerns. The applicable North American Industry Classification Standard Code is 325414 The small business size standard is 1,250 employees This acquisition is a Total Small Business Set-Aside. All responsible sources may submit a quotation which will be considered by the agency.
Key dates
- Posted
- October 19, 2026
- Response due
- October 30, 2026
Who is this buyer
Organization
Buying history
- Records44 total
- Opportunities / awards3 / 7
- Value range$29,775 – $190,000
- ActiveJuly 16, 2026 – October 20, 2026
What they buy
- Clinical (25)
- Administrative (18)
- Insurance (1)
Set-asides used
- Small Business Set Aside - Total (26)
- No Set aside used (11)
Who holds their work today
- INGENESIS INC1 win · $190,000 · last December 4, 2025
- MCFARLAND CLINIC PC1 win · $36,366 · last October 16, 2020
Also open from this buyer
- Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)Due November 10, 2026 · Clinical
- NAHLN Diagnostic Testing ServicesDue June 16, 2027 · Clinical
View source document →
Source link on sam.gov.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- Small Business Set Aside - Total
- NAICS
- 325414
- PSC
- 6509